A multidistrict litigation (MDL) has been created for lawsuits alleging permanent hair loss resulting from use of the chemotherapy drug Taxotere. On October 4, 2016, the United States Judicial Panel on Multidistrict Litigation (JPML) granted a motion to transfer and consolidate these cases after considering input from counsel for Plaintiffs and Defendants. Zoll & Kranz, LLC was one of the firms involved in this process, having filed a response supporting the consolidation of the cases and creation of the MDL. The newly-formed MDL is titled MDL No. 2740 IN RE: Taxotere (Docetaxel) Products Liability Litigation.
The JPML also chose to consolidate the cases in the Eastern District of Louisiana before the Honorable Judge Kurt D. Engelhardt. This means that the cases filed in federal court alleging that Taxotere caused permanent hair loss and that the manufacturer Sanofi-Aventis did not warn of the risk will be transferred before Hon. Judge Engelhardt.
Learn More About The Taxotere Lawsuit
MDLs are commonly confused with class actions. Although they are both litigations in which multiple people allege similar injuries caused by the same problem, there are significant differences. Importantly, because cases in an MDL do not share the same very high degree of similarity required for a class action, MDLs are structured to handle common issues while preserving the individual nature of the lawsuits. You can learn more about multidistrict litigation here or by contacting our experienced and knowledgeable MDL and mass tort lawyers toll free at (888)841-9623.
Zoll & Kranz is continuing to investigate a potential connection between the chemotherapy drug Taxotere and permanent hair loss. If you believe you or a loved one may have been affected by the use of Taxotere, we offer a free case evaluation. You can reach our caring and experienced Taxotere lawsuit team through our form on the webpage linked here or call toll-free at 888-841-9623.
Michelle is a founding partner of Zoll & Kranz, located in Toledo, Ohio. Michelle has been a plaintiff’s lawyer for the entirety of her practice – over 32 years. She devotes the majority of her time to complex consolidated litigation and class action including advocating for people injured by medical devices, prescription medications, or corporate negligence.
This article has been written and reviewed for legal accuracy and clarity by the team of writers and attorneys at Zoll & Kranz, LLC and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced Ohio injury lawyer, Michelle L. Kranz, you can do so here.
Zoll & Kranz, LLC does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us. This article should not be taken as advice from an attorney.
A serious injury can have life-altering results.
Don’t settle for less than you deserve, speak with an award-winning personal injury lawyer today.
FDA Warns Pfizer’s Drug Tygacil Raises Risk of Death
FDA Announces da Vinci Surgical System Robot Recall
FDA Issues Warning Over Phillips Heart Defibrillators
FDA Issues Warning About Medtronic Guidewire Recall
Unsterile Medical Device Recall: Zoll & Kranz, LLC is investigating the Seprafilm Class II Recall
For over 37 years, Zoll & Kranz has been fighting for clients who have been the victims of the wrongful death of a loved one.
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
A serious injury can have life-altering results.
Don’t settle for less than you deserve, speak with an award-winning personal injury lawyer today.